Inhaler devices: the past, the present, and the future 03:37 Inhaler devices: the past, the present, and the future Inhaler devices: the past, the present, and the future Posted on: Sara Stream2MD Inhaler devices: the past, the present, and the future
Mechanism and Inhibition of Airway Inflammation in Asthma 01:29 Mechanism and Inhibition of Airway Inflammation in Asthma Mechanism and Inhibition of Airway Inflammation in Asthma Posted on: Blausen Medical Mechanism and Inhibition of Airway Inflammation in Asthma
Professor Marek Lommatzsch explores the use of severe asthma biologics. 26:58 Professor Marek Lommatzsch explores the use of severe asthma biologics. Professor Marek Lommatzsch explores the use of severe asthma biologics. Posted on: TEVA Respiratory Professor Marek Lommatzsch explores the use of severe asthma biologics.
Professor Marc Humbert discusses biologics in asthma, and beyond. 35:43 Professor Marc Humbert discusses biologics in asthma, and beyond. Professor Marc Humbert discusses biologics in asthma, and beyond. Posted on: TEVA Respiratory Professor Marc Humbert discusses biologics in asthma, and beyond.
Professor Christian Virchow examines the use of biomarkers in asthma treatment. 28:50 Professor Christian Virchow examines the use of biomarkers in asthma treatment. Professor Christian Virchow examines the use of biomarkers in asthma treatment. Posted on: TEVA Respiratory Professor Christian Virchow examines the use of biomarkers in asthma treatment.
Introduction to the EAACI congress by Professor Vibeke Backer. 04:05 Introduction to the EAACI congress by Professor Vibeke Backer. Introduction to the EAACI congress by Professor Vibeke Backer. Posted on: TEVA Respiratory Introduction to the EAACI congress by Professor Vibeke Backer.
Professor Guy Brusselle explores anti-IL-5 therapy, from clinical trials to clinical practice. 28:28 Professor Guy Brusselle explores anti-IL-5 therapy, from clinical trials to clinical practice. Professor Guy Brusselle explores anti-IL-5 therapy, from clinical trials to clinical practice. Posted on: TEVA Respiratory Professor Guy Brusselle explores anti-IL-5 therapy, from clinical trials to clinical practice.
Professor Dave Singh discusses identfying severe eosinophilic asthma patients. 23:07 Professor Dave Singh discusses identfying severe eosinophilic asthma patients. Professor Dave Singh discusses identfying severe eosinophilic asthma patients. Posted on: TEVA Respiratory Professor Dave Singh discusses identfying severe eosinophilic asthma patients.
Knowing your asthma triggers 01:22 Knowing your asthma triggers Knowing your asthma triggers Posted on: TEVA Respiratory Knowing your asthma triggers
ERS 2017 Teva Respiratory Highlights 01:09 ERS 2017 Teva Respiratory Highlights ERS 2017 Teva Respiratory Highlights Posted on: TEVA Respiratory ERS 2017 Teva Respiratory Highlights
